nodes	percent_of_prediction	percent_of_DWPC	metapath
Rivaroxaban—ABCB1—ovarian cancer	0.402	1	CbGaD
Rivaroxaban—ABCB1—Topotecan—ovarian cancer	0.064	0.172	CbGbCtD
Rivaroxaban—CYP3A5—Paclitaxel—ovarian cancer	0.0487	0.131	CbGbCtD
Rivaroxaban—ABCB1—Vinorelbine—ovarian cancer	0.0451	0.121	CbGbCtD
Rivaroxaban—CYP3A4—Topotecan—ovarian cancer	0.0384	0.103	CbGbCtD
Rivaroxaban—CYP3A5—Docetaxel—ovarian cancer	0.0352	0.0944	CbGbCtD
Rivaroxaban—ABCB1—Paclitaxel—ovarian cancer	0.0317	0.0849	CbGbCtD
Rivaroxaban—CYP3A4—Vinorelbine—ovarian cancer	0.027	0.0724	CbGbCtD
Rivaroxaban—ABCB1—Docetaxel—ovarian cancer	0.0229	0.0614	CbGbCtD
Rivaroxaban—CYP3A4—Paclitaxel—ovarian cancer	0.019	0.0509	CbGbCtD
Rivaroxaban—ABCB1—Doxorubicin—ovarian cancer	0.0171	0.0458	CbGbCtD
Rivaroxaban—CYP3A4—Docetaxel—ovarian cancer	0.0137	0.0368	CbGbCtD
Rivaroxaban—CYP3A4—Doxorubicin—ovarian cancer	0.0102	0.0274	CbGbCtD
Rivaroxaban—F10—uterine cervix—ovarian cancer	0.00363	0.085	CbGeAlD
Rivaroxaban—F10—decidua—ovarian cancer	0.00346	0.081	CbGeAlD
Rivaroxaban—F10—endometrium—ovarian cancer	0.00328	0.0769	CbGeAlD
Rivaroxaban—F10—female reproductive system—ovarian cancer	0.00272	0.0637	CbGeAlD
Rivaroxaban—CYP2J2—endometrium—ovarian cancer	0.00269	0.063	CbGeAlD
Rivaroxaban—CYP2J2—uterus—ovarian cancer	0.00248	0.0581	CbGeAlD
Rivaroxaban—F10—female gonad—ovarian cancer	0.00247	0.0579	CbGeAlD
Rivaroxaban—F10—vagina—ovarian cancer	0.00246	0.0576	CbGeAlD
Rivaroxaban—CYP2J2—female reproductive system—ovarian cancer	0.00223	0.0522	CbGeAlD
Rivaroxaban—F10—testis—ovarian cancer	0.0022	0.0514	CbGeAlD
Rivaroxaban—CYP2J2—vagina—ovarian cancer	0.00202	0.0472	CbGeAlD
Rivaroxaban—CYP2J2—testis—ovarian cancer	0.0018	0.0421	CbGeAlD
Rivaroxaban—F10—lymph node—ovarian cancer	0.00159	0.0373	CbGeAlD
Rivaroxaban—CYP3A5—uterine cervix—ovarian cancer	0.00105	0.0245	CbGeAlD
Rivaroxaban—ABCB1—myometrium—ovarian cancer	0.000715	0.0167	CbGeAlD
Rivaroxaban—CYP3A5—female gonad—ovarian cancer	0.000714	0.0167	CbGeAlD
Rivaroxaban—CYP3A5—vagina—ovarian cancer	0.00071	0.0166	CbGeAlD
Rivaroxaban—ABCB1—embryo—ovarian cancer	0.000688	0.0161	CbGeAlD
Rivaroxaban—CYP3A4—female reproductive system—ovarian cancer	0.000589	0.0138	CbGeAlD
Rivaroxaban—ABCB1—epithelium—ovarian cancer	0.000561	0.0131	CbGeAlD
Rivaroxaban—ABCB1—uterine cervix—ovarian cancer	0.000556	0.013	CbGeAlD
Rivaroxaban—ABCB1—decidua—ovarian cancer	0.00053	0.0124	CbGeAlD
Rivaroxaban—ABCB1—endometrium—ovarian cancer	0.000503	0.0118	CbGeAlD
Rivaroxaban—ABCB1—gonad—ovarian cancer	0.000467	0.0109	CbGeAlD
Rivaroxaban—ABCB1—uterus—ovarian cancer	0.000464	0.0109	CbGeAlD
Rivaroxaban—ABCB1—female reproductive system—ovarian cancer	0.000417	0.00976	CbGeAlD
Rivaroxaban—ABCB1—bone marrow—ovarian cancer	0.000393	0.00921	CbGeAlD
Rivaroxaban—ABCB1—female gonad—ovarian cancer	0.000379	0.00888	CbGeAlD
Rivaroxaban—ABCB1—vagina—ovarian cancer	0.000377	0.00882	CbGeAlD
Rivaroxaban—ABCB1—testis—ovarian cancer	0.000336	0.00787	CbGeAlD
Rivaroxaban—Haemoglobin—Docetaxel—ovarian cancer	0.000304	0.00167	CcSEcCtD
Rivaroxaban—Hepatitis—Docetaxel—ovarian cancer	0.000302	0.00166	CcSEcCtD
Rivaroxaban—Haemorrhage—Docetaxel—ovarian cancer	0.000302	0.00166	CcSEcCtD
Rivaroxaban—Diarrhoea—Topotecan—ovarian cancer	0.000301	0.00165	CcSEcCtD
Rivaroxaban—Back pain—Paclitaxel—ovarian cancer	0.0003	0.00165	CcSEcCtD
Rivaroxaban—Urticaria—Vinorelbine—ovarian cancer	0.000299	0.00164	CcSEcCtD
Rivaroxaban—Urinary tract disorder—Docetaxel—ovarian cancer	0.000298	0.00164	CcSEcCtD
Rivaroxaban—Muscle spasms—Paclitaxel—ovarian cancer	0.000298	0.00164	CcSEcCtD
Rivaroxaban—Abdominal pain—Vinorelbine—ovarian cancer	0.000298	0.00163	CcSEcCtD
Rivaroxaban—Connective tissue disorder—Docetaxel—ovarian cancer	0.000297	0.00163	CcSEcCtD
Rivaroxaban—Urethral disorder—Docetaxel—ovarian cancer	0.000296	0.00162	CcSEcCtD
Rivaroxaban—Renal failure acute—Doxorubicin—ovarian cancer	0.000295	0.00162	CcSEcCtD
Rivaroxaban—Diarrhoea—Melphalan—ovarian cancer	0.000295	0.00162	CcSEcCtD
Rivaroxaban—Pain in extremity—Epirubicin—ovarian cancer	0.000295	0.00162	CcSEcCtD
Rivaroxaban—Gastrointestinal haemorrhage—Epirubicin—ovarian cancer	0.000295	0.00162	CcSEcCtD
Rivaroxaban—Osteoarthritis—Epirubicin—ovarian cancer	0.000295	0.00162	CcSEcCtD
Rivaroxaban—Nausea—Chlorambucil—ovarian cancer	0.000294	0.00161	CcSEcCtD
Rivaroxaban—Dizziness—Topotecan—ovarian cancer	0.000291	0.0016	CcSEcCtD
Rivaroxaban—Ill-defined disorder—Paclitaxel—ovarian cancer	0.000288	0.00158	CcSEcCtD
Rivaroxaban—Anaemia—Paclitaxel—ovarian cancer	0.000287	0.00157	CcSEcCtD
Rivaroxaban—Erythema multiforme—Docetaxel—ovarian cancer	0.000286	0.00157	CcSEcCtD
Rivaroxaban—Dermatitis bullous—Doxorubicin—ovarian cancer	0.000285	0.00156	CcSEcCtD
Rivaroxaban—Angioedema—Paclitaxel—ovarian cancer	0.000284	0.00156	CcSEcCtD
Rivaroxaban—Eye disorder—Docetaxel—ovarian cancer	0.000282	0.00155	CcSEcCtD
Rivaroxaban—Cardiac disorder—Docetaxel—ovarian cancer	0.00028	0.00154	CcSEcCtD
Rivaroxaban—Vomiting—Topotecan—ovarian cancer	0.00028	0.00154	CcSEcCtD
Rivaroxaban—Malaise—Paclitaxel—ovarian cancer	0.00028	0.00154	CcSEcCtD
Rivaroxaban—Syncope—Paclitaxel—ovarian cancer	0.000278	0.00153	CcSEcCtD
Rivaroxaban—Rash—Topotecan—ovarian cancer	0.000278	0.00152	CcSEcCtD
Rivaroxaban—Hypersensitivity—Vinorelbine—ovarian cancer	0.000277	0.00152	CcSEcCtD
Rivaroxaban—Dermatitis—Topotecan—ovarian cancer	0.000277	0.00152	CcSEcCtD
Rivaroxaban—Blood creatinine increased—Epirubicin—ovarian cancer	0.000276	0.00151	CcSEcCtD
Rivaroxaban—Headache—Topotecan—ovarian cancer	0.000276	0.00151	CcSEcCtD
Rivaroxaban—Angiopathy—Docetaxel—ovarian cancer	0.000274	0.0015	CcSEcCtD
Rivaroxaban—Vomiting—Melphalan—ovarian cancer	0.000274	0.0015	CcSEcCtD
Rivaroxaban—Immune system disorder—Docetaxel—ovarian cancer	0.000273	0.0015	CcSEcCtD
Rivaroxaban—Loss of consciousness—Paclitaxel—ovarian cancer	0.000273	0.0015	CcSEcCtD
Rivaroxaban—Gastrointestinal haemorrhage—Doxorubicin—ovarian cancer	0.000273	0.0015	CcSEcCtD
Rivaroxaban—Pain in extremity—Doxorubicin—ovarian cancer	0.000273	0.0015	CcSEcCtD
Rivaroxaban—Osteoarthritis—Doxorubicin—ovarian cancer	0.000273	0.0015	CcSEcCtD
Rivaroxaban—Mediastinal disorder—Docetaxel—ovarian cancer	0.000272	0.00149	CcSEcCtD
Rivaroxaban—Rash—Melphalan—ovarian cancer	0.000272	0.00149	CcSEcCtD
Rivaroxaban—Dermatitis—Melphalan—ovarian cancer	0.000272	0.00149	CcSEcCtD
Rivaroxaban—Asthenia—Vinorelbine—ovarian cancer	0.00027	0.00148	CcSEcCtD
Rivaroxaban—Abdominal pain upper—Epirubicin—ovarian cancer	0.000269	0.00148	CcSEcCtD
Rivaroxaban—Pruritus—Vinorelbine—ovarian cancer	0.000266	0.00146	CcSEcCtD
Rivaroxaban—Chest pain—Paclitaxel—ovarian cancer	0.000264	0.00145	CcSEcCtD
Rivaroxaban—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—ovarian cancer	0.000262	0.00144	CcSEcCtD
Rivaroxaban—Nausea—Topotecan—ovarian cancer	0.000261	0.00143	CcSEcCtD
Rivaroxaban—Discomfort—Paclitaxel—ovarian cancer	0.000261	0.00143	CcSEcCtD
Rivaroxaban—Dry mouth—Paclitaxel—ovarian cancer	0.000258	0.00142	CcSEcCtD
Rivaroxaban—Diarrhoea—Vinorelbine—ovarian cancer	0.000258	0.00141	CcSEcCtD
Rivaroxaban—Nausea—Melphalan—ovarian cancer	0.000256	0.0014	CcSEcCtD
Rivaroxaban—Blood creatinine increased—Doxorubicin—ovarian cancer	0.000255	0.0014	CcSEcCtD
Rivaroxaban—Back pain—Docetaxel—ovarian cancer	0.000254	0.0014	CcSEcCtD
Rivaroxaban—Anaphylactic shock—Paclitaxel—ovarian cancer	0.000253	0.00139	CcSEcCtD
Rivaroxaban—Oedema—Paclitaxel—ovarian cancer	0.000253	0.00139	CcSEcCtD
Rivaroxaban—Muscle spasms—Docetaxel—ovarian cancer	0.000253	0.00139	CcSEcCtD
Rivaroxaban—Infection—Paclitaxel—ovarian cancer	0.000252	0.00138	CcSEcCtD
Rivaroxaban—Shock—Paclitaxel—ovarian cancer	0.000249	0.00137	CcSEcCtD
Rivaroxaban—Dizziness—Vinorelbine—ovarian cancer	0.000249	0.00137	CcSEcCtD
Rivaroxaban—Abdominal pain upper—Doxorubicin—ovarian cancer	0.000249	0.00137	CcSEcCtD
Rivaroxaban—Nervous system disorder—Paclitaxel—ovarian cancer	0.000248	0.00136	CcSEcCtD
Rivaroxaban—Angina pectoris—Epirubicin—ovarian cancer	0.000248	0.00136	CcSEcCtD
Rivaroxaban—Tachycardia—Paclitaxel—ovarian cancer	0.000247	0.00136	CcSEcCtD
Rivaroxaban—Skin disorder—Paclitaxel—ovarian cancer	0.000246	0.00135	CcSEcCtD
Rivaroxaban—ABCB1—lymph node—ovarian cancer	0.000244	0.00571	CbGeAlD
Rivaroxaban—Anaemia—Docetaxel—ovarian cancer	0.000243	0.00133	CcSEcCtD
Rivaroxaban—Vomiting—Vinorelbine—ovarian cancer	0.000239	0.00131	CcSEcCtD
Rivaroxaban—Rash—Vinorelbine—ovarian cancer	0.000237	0.0013	CcSEcCtD
Rivaroxaban—Dermatitis—Vinorelbine—ovarian cancer	0.000237	0.0013	CcSEcCtD
Rivaroxaban—Hypotension—Paclitaxel—ovarian cancer	0.000237	0.0013	CcSEcCtD
Rivaroxaban—Headache—Vinorelbine—ovarian cancer	0.000236	0.00129	CcSEcCtD
Rivaroxaban—Syncope—Docetaxel—ovarian cancer	0.000236	0.00129	CcSEcCtD
Rivaroxaban—Loss of consciousness—Docetaxel—ovarian cancer	0.000231	0.00127	CcSEcCtD
Rivaroxaban—Angina pectoris—Doxorubicin—ovarian cancer	0.00023	0.00126	CcSEcCtD
Rivaroxaban—Infestation NOS—Epirubicin—ovarian cancer	0.000227	0.00125	CcSEcCtD
Rivaroxaban—Infestation—Epirubicin—ovarian cancer	0.000227	0.00125	CcSEcCtD
Rivaroxaban—Dyspnoea—Paclitaxel—ovarian cancer	0.000226	0.00124	CcSEcCtD
Rivaroxaban—Stevens-Johnson syndrome—Epirubicin—ovarian cancer	0.000225	0.00123	CcSEcCtD
Rivaroxaban—Chest pain—Docetaxel—ovarian cancer	0.000224	0.00123	CcSEcCtD
Rivaroxaban—Nausea—Vinorelbine—ovarian cancer	0.000224	0.00123	CcSEcCtD
Rivaroxaban—Renal failure—Epirubicin—ovarian cancer	0.000223	0.00122	CcSEcCtD
Rivaroxaban—Dyspepsia—Paclitaxel—ovarian cancer	0.000223	0.00122	CcSEcCtD
Rivaroxaban—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—ovarian cancer	0.000222	0.00122	CcSEcCtD
Rivaroxaban—Jaundice—Epirubicin—ovarian cancer	0.000221	0.00121	CcSEcCtD
Rivaroxaban—Urinary tract infection—Epirubicin—ovarian cancer	0.000221	0.00121	CcSEcCtD
Rivaroxaban—Dry mouth—Docetaxel—ovarian cancer	0.000219	0.0012	CcSEcCtD
Rivaroxaban—Gastrointestinal disorder—Paclitaxel—ovarian cancer	0.000219	0.0012	CcSEcCtD
Rivaroxaban—Fatigue—Paclitaxel—ovarian cancer	0.000218	0.0012	CcSEcCtD
Rivaroxaban—Pain—Paclitaxel—ovarian cancer	0.000217	0.00119	CcSEcCtD
Rivaroxaban—Constipation—Paclitaxel—ovarian cancer	0.000217	0.00119	CcSEcCtD
Rivaroxaban—Haematuria—Epirubicin—ovarian cancer	0.000216	0.00119	CcSEcCtD
Rivaroxaban—Hepatobiliary disease—Epirubicin—ovarian cancer	0.000215	0.00118	CcSEcCtD
Rivaroxaban—Anaphylactic shock—Docetaxel—ovarian cancer	0.000215	0.00118	CcSEcCtD
Rivaroxaban—Oedema—Docetaxel—ovarian cancer	0.000215	0.00118	CcSEcCtD
Rivaroxaban—Epistaxis—Epirubicin—ovarian cancer	0.000214	0.00117	CcSEcCtD
Rivaroxaban—Infection—Docetaxel—ovarian cancer	0.000213	0.00117	CcSEcCtD
Rivaroxaban—Sinusitis—Epirubicin—ovarian cancer	0.000213	0.00117	CcSEcCtD
Rivaroxaban—Agranulocytosis—Epirubicin—ovarian cancer	0.000212	0.00116	CcSEcCtD
Rivaroxaban—Shock—Docetaxel—ovarian cancer	0.000211	0.00116	CcSEcCtD
Rivaroxaban—Nervous system disorder—Docetaxel—ovarian cancer	0.000211	0.00115	CcSEcCtD
Rivaroxaban—Infestation NOS—Doxorubicin—ovarian cancer	0.00021	0.00115	CcSEcCtD
Rivaroxaban—Infestation—Doxorubicin—ovarian cancer	0.00021	0.00115	CcSEcCtD
Rivaroxaban—Tachycardia—Docetaxel—ovarian cancer	0.00021	0.00115	CcSEcCtD
Rivaroxaban—Feeling abnormal—Paclitaxel—ovarian cancer	0.000209	0.00114	CcSEcCtD
Rivaroxaban—Skin disorder—Docetaxel—ovarian cancer	0.000209	0.00114	CcSEcCtD
Rivaroxaban—Stevens-Johnson syndrome—Doxorubicin—ovarian cancer	0.000208	0.00114	CcSEcCtD
Rivaroxaban—Gastrointestinal pain—Paclitaxel—ovarian cancer	0.000207	0.00114	CcSEcCtD
Rivaroxaban—Renal failure—Doxorubicin—ovarian cancer	0.000207	0.00113	CcSEcCtD
Rivaroxaban—Haemoglobin—Epirubicin—ovarian cancer	0.000205	0.00112	CcSEcCtD
Rivaroxaban—Jaundice—Doxorubicin—ovarian cancer	0.000205	0.00112	CcSEcCtD
Rivaroxaban—Urinary tract infection—Doxorubicin—ovarian cancer	0.000204	0.00112	CcSEcCtD
Rivaroxaban—Hepatitis—Epirubicin—ovarian cancer	0.000204	0.00112	CcSEcCtD
Rivaroxaban—Haemorrhage—Epirubicin—ovarian cancer	0.000204	0.00112	CcSEcCtD
Rivaroxaban—Urinary tract disorder—Epirubicin—ovarian cancer	0.000201	0.0011	CcSEcCtD
Rivaroxaban—Urticaria—Paclitaxel—ovarian cancer	0.000201	0.0011	CcSEcCtD
Rivaroxaban—Hypotension—Docetaxel—ovarian cancer	0.000201	0.0011	CcSEcCtD
Rivaroxaban—Haematuria—Doxorubicin—ovarian cancer	0.0002	0.0011	CcSEcCtD
Rivaroxaban—Connective tissue disorder—Epirubicin—ovarian cancer	0.0002	0.0011	CcSEcCtD
Rivaroxaban—Abdominal pain—Paclitaxel—ovarian cancer	0.0002	0.0011	CcSEcCtD
Rivaroxaban—Urethral disorder—Epirubicin—ovarian cancer	0.0002	0.0011	CcSEcCtD
Rivaroxaban—Hepatobiliary disease—Doxorubicin—ovarian cancer	0.000199	0.00109	CcSEcCtD
Rivaroxaban—Epistaxis—Doxorubicin—ovarian cancer	0.000198	0.00109	CcSEcCtD
Rivaroxaban—Sinusitis—Doxorubicin—ovarian cancer	0.000197	0.00108	CcSEcCtD
Rivaroxaban—Agranulocytosis—Doxorubicin—ovarian cancer	0.000196	0.00108	CcSEcCtD
Rivaroxaban—Erythema multiforme—Epirubicin—ovarian cancer	0.000193	0.00106	CcSEcCtD
Rivaroxaban—Dyspnoea—Docetaxel—ovarian cancer	0.000191	0.00105	CcSEcCtD
Rivaroxaban—Eye disorder—Epirubicin—ovarian cancer	0.00019	0.00104	CcSEcCtD
Rivaroxaban—Haemoglobin—Doxorubicin—ovarian cancer	0.00019	0.00104	CcSEcCtD
Rivaroxaban—Cardiac disorder—Epirubicin—ovarian cancer	0.000189	0.00104	CcSEcCtD
Rivaroxaban—Dyspepsia—Docetaxel—ovarian cancer	0.000189	0.00104	CcSEcCtD
Rivaroxaban—Hepatitis—Doxorubicin—ovarian cancer	0.000189	0.00103	CcSEcCtD
Rivaroxaban—Haemorrhage—Doxorubicin—ovarian cancer	0.000189	0.00103	CcSEcCtD
Rivaroxaban—Hypersensitivity—Paclitaxel—ovarian cancer	0.000187	0.00102	CcSEcCtD
Rivaroxaban—Urinary tract disorder—Doxorubicin—ovarian cancer	0.000186	0.00102	CcSEcCtD
Rivaroxaban—Gastrointestinal disorder—Docetaxel—ovarian cancer	0.000185	0.00102	CcSEcCtD
Rivaroxaban—Connective tissue disorder—Doxorubicin—ovarian cancer	0.000185	0.00102	CcSEcCtD
Rivaroxaban—Fatigue—Docetaxel—ovarian cancer	0.000185	0.00102	CcSEcCtD
Rivaroxaban—Angiopathy—Epirubicin—ovarian cancer	0.000185	0.00101	CcSEcCtD
Rivaroxaban—Urethral disorder—Doxorubicin—ovarian cancer	0.000185	0.00101	CcSEcCtD
Rivaroxaban—Immune system disorder—Epirubicin—ovarian cancer	0.000184	0.00101	CcSEcCtD
Rivaroxaban—Mediastinal disorder—Epirubicin—ovarian cancer	0.000184	0.00101	CcSEcCtD
Rivaroxaban—Pain—Docetaxel—ovarian cancer	0.000184	0.00101	CcSEcCtD
Rivaroxaban—Constipation—Docetaxel—ovarian cancer	0.000184	0.00101	CcSEcCtD
Rivaroxaban—Asthenia—Paclitaxel—ovarian cancer	0.000182	0.000997	CcSEcCtD
Rivaroxaban—Pruritus—Paclitaxel—ovarian cancer	0.000179	0.000983	CcSEcCtD
Rivaroxaban—Erythema multiforme—Doxorubicin—ovarian cancer	0.000178	0.000978	CcSEcCtD
Rivaroxaban—Feeling abnormal—Docetaxel—ovarian cancer	0.000177	0.00097	CcSEcCtD
Rivaroxaban—Eye disorder—Doxorubicin—ovarian cancer	0.000176	0.000967	CcSEcCtD
Rivaroxaban—Gastrointestinal pain—Docetaxel—ovarian cancer	0.000176	0.000963	CcSEcCtD
Rivaroxaban—Cardiac disorder—Doxorubicin—ovarian cancer	0.000175	0.00096	CcSEcCtD
Rivaroxaban—Diarrhoea—Paclitaxel—ovarian cancer	0.000173	0.000951	CcSEcCtD
Rivaroxaban—Back pain—Epirubicin—ovarian cancer	0.000172	0.000941	CcSEcCtD
Rivaroxaban—Angiopathy—Doxorubicin—ovarian cancer	0.000171	0.000939	CcSEcCtD
Rivaroxaban—Muscle spasms—Epirubicin—ovarian cancer	0.000171	0.000936	CcSEcCtD
Rivaroxaban—Immune system disorder—Doxorubicin—ovarian cancer	0.00017	0.000934	CcSEcCtD
Rivaroxaban—Mediastinal disorder—Doxorubicin—ovarian cancer	0.00017	0.000932	CcSEcCtD
Rivaroxaban—Abdominal pain—Docetaxel—ovarian cancer	0.00017	0.000931	CcSEcCtD
Rivaroxaban—Dizziness—Paclitaxel—ovarian cancer	0.000167	0.000919	CcSEcCtD
Rivaroxaban—Ill-defined disorder—Epirubicin—ovarian cancer	0.000165	0.000903	CcSEcCtD
Rivaroxaban—Anaemia—Epirubicin—ovarian cancer	0.000164	0.0009	CcSEcCtD
Rivaroxaban—Vomiting—Paclitaxel—ovarian cancer	0.000161	0.000883	CcSEcCtD
Rivaroxaban—Malaise—Epirubicin—ovarian cancer	0.00016	0.000878	CcSEcCtD
Rivaroxaban—Rash—Paclitaxel—ovarian cancer	0.00016	0.000876	CcSEcCtD
Rivaroxaban—Dermatitis—Paclitaxel—ovarian cancer	0.00016	0.000875	CcSEcCtD
Rivaroxaban—Syncope—Epirubicin—ovarian cancer	0.000159	0.000873	CcSEcCtD
Rivaroxaban—Back pain—Doxorubicin—ovarian cancer	0.000159	0.000871	CcSEcCtD
Rivaroxaban—Headache—Paclitaxel—ovarian cancer	0.000159	0.00087	CcSEcCtD
Rivaroxaban—Hypersensitivity—Docetaxel—ovarian cancer	0.000158	0.000868	CcSEcCtD
Rivaroxaban—Muscle spasms—Doxorubicin—ovarian cancer	0.000158	0.000866	CcSEcCtD
Rivaroxaban—Loss of consciousness—Epirubicin—ovarian cancer	0.000156	0.000855	CcSEcCtD
Rivaroxaban—Asthenia—Docetaxel—ovarian cancer	0.000154	0.000845	CcSEcCtD
Rivaroxaban—Ill-defined disorder—Doxorubicin—ovarian cancer	0.000152	0.000836	CcSEcCtD
Rivaroxaban—Pruritus—Docetaxel—ovarian cancer	0.000152	0.000833	CcSEcCtD
Rivaroxaban—Anaemia—Doxorubicin—ovarian cancer	0.000152	0.000832	CcSEcCtD
Rivaroxaban—Chest pain—Epirubicin—ovarian cancer	0.000151	0.000829	CcSEcCtD
Rivaroxaban—Nausea—Paclitaxel—ovarian cancer	0.00015	0.000825	CcSEcCtD
Rivaroxaban—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—ovarian cancer	0.00015	0.000823	CcSEcCtD
Rivaroxaban—Discomfort—Epirubicin—ovarian cancer	0.000149	0.000819	CcSEcCtD
Rivaroxaban—Malaise—Doxorubicin—ovarian cancer	0.000148	0.000812	CcSEcCtD
Rivaroxaban—Dry mouth—Epirubicin—ovarian cancer	0.000148	0.00081	CcSEcCtD
Rivaroxaban—Syncope—Doxorubicin—ovarian cancer	0.000147	0.000808	CcSEcCtD
Rivaroxaban—Diarrhoea—Docetaxel—ovarian cancer	0.000147	0.000806	CcSEcCtD
Rivaroxaban—Oedema—Epirubicin—ovarian cancer	0.000145	0.000794	CcSEcCtD
Rivaroxaban—Anaphylactic shock—Epirubicin—ovarian cancer	0.000145	0.000794	CcSEcCtD
Rivaroxaban—Loss of consciousness—Doxorubicin—ovarian cancer	0.000144	0.000791	CcSEcCtD
Rivaroxaban—Infection—Epirubicin—ovarian cancer	0.000144	0.000789	CcSEcCtD
Rivaroxaban—Shock—Epirubicin—ovarian cancer	0.000142	0.000781	CcSEcCtD
Rivaroxaban—Nervous system disorder—Epirubicin—ovarian cancer	0.000142	0.000779	CcSEcCtD
Rivaroxaban—Dizziness—Docetaxel—ovarian cancer	0.000142	0.000779	CcSEcCtD
Rivaroxaban—Tachycardia—Epirubicin—ovarian cancer	0.000141	0.000775	CcSEcCtD
Rivaroxaban—Skin disorder—Epirubicin—ovarian cancer	0.000141	0.000772	CcSEcCtD
Rivaroxaban—Chest pain—Doxorubicin—ovarian cancer	0.00014	0.000767	CcSEcCtD
Rivaroxaban—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—ovarian cancer	0.000139	0.000761	CcSEcCtD
Rivaroxaban—Discomfort—Doxorubicin—ovarian cancer	0.000138	0.000757	CcSEcCtD
Rivaroxaban—Dry mouth—Doxorubicin—ovarian cancer	0.000137	0.00075	CcSEcCtD
Rivaroxaban—Vomiting—Docetaxel—ovarian cancer	0.000136	0.000749	CcSEcCtD
Rivaroxaban—Rash—Docetaxel—ovarian cancer	0.000135	0.000743	CcSEcCtD
Rivaroxaban—Hypotension—Epirubicin—ovarian cancer	0.000135	0.000742	CcSEcCtD
Rivaroxaban—Dermatitis—Docetaxel—ovarian cancer	0.000135	0.000742	CcSEcCtD
Rivaroxaban—Headache—Docetaxel—ovarian cancer	0.000134	0.000738	CcSEcCtD
Rivaroxaban—Anaphylactic shock—Doxorubicin—ovarian cancer	0.000134	0.000735	CcSEcCtD
Rivaroxaban—Oedema—Doxorubicin—ovarian cancer	0.000134	0.000735	CcSEcCtD
Rivaroxaban—Infection—Doxorubicin—ovarian cancer	0.000133	0.00073	CcSEcCtD
Rivaroxaban—Shock—Doxorubicin—ovarian cancer	0.000132	0.000723	CcSEcCtD
Rivaroxaban—Nervous system disorder—Doxorubicin—ovarian cancer	0.000131	0.000721	CcSEcCtD
Rivaroxaban—Tachycardia—Doxorubicin—ovarian cancer	0.000131	0.000717	CcSEcCtD
Rivaroxaban—Skin disorder—Doxorubicin—ovarian cancer	0.00013	0.000714	CcSEcCtD
Rivaroxaban—Dyspnoea—Epirubicin—ovarian cancer	0.000129	0.000708	CcSEcCtD
Rivaroxaban—Nausea—Docetaxel—ovarian cancer	0.000128	0.0007	CcSEcCtD
Rivaroxaban—Dyspepsia—Epirubicin—ovarian cancer	0.000127	0.000699	CcSEcCtD
Rivaroxaban—Hypotension—Doxorubicin—ovarian cancer	0.000125	0.000687	CcSEcCtD
Rivaroxaban—Gastrointestinal disorder—Epirubicin—ovarian cancer	0.000125	0.000686	CcSEcCtD
Rivaroxaban—Fatigue—Epirubicin—ovarian cancer	0.000125	0.000685	CcSEcCtD
Rivaroxaban—Pain—Epirubicin—ovarian cancer	0.000124	0.000679	CcSEcCtD
Rivaroxaban—Constipation—Epirubicin—ovarian cancer	0.000124	0.000679	CcSEcCtD
Rivaroxaban—Dyspnoea—Doxorubicin—ovarian cancer	0.000119	0.000655	CcSEcCtD
Rivaroxaban—Feeling abnormal—Epirubicin—ovarian cancer	0.000119	0.000655	CcSEcCtD
Rivaroxaban—Gastrointestinal pain—Epirubicin—ovarian cancer	0.000118	0.00065	CcSEcCtD
Rivaroxaban—Dyspepsia—Doxorubicin—ovarian cancer	0.000118	0.000647	CcSEcCtD
Rivaroxaban—Gastrointestinal disorder—Doxorubicin—ovarian cancer	0.000116	0.000635	CcSEcCtD
Rivaroxaban—Fatigue—Doxorubicin—ovarian cancer	0.000116	0.000634	CcSEcCtD
Rivaroxaban—Urticaria—Epirubicin—ovarian cancer	0.000115	0.000631	CcSEcCtD
Rivaroxaban—Pain—Doxorubicin—ovarian cancer	0.000115	0.000628	CcSEcCtD
Rivaroxaban—Constipation—Doxorubicin—ovarian cancer	0.000115	0.000628	CcSEcCtD
Rivaroxaban—Abdominal pain—Epirubicin—ovarian cancer	0.000114	0.000628	CcSEcCtD
Rivaroxaban—Feeling abnormal—Doxorubicin—ovarian cancer	0.00011	0.000606	CcSEcCtD
Rivaroxaban—Gastrointestinal pain—Doxorubicin—ovarian cancer	0.00011	0.000601	CcSEcCtD
Rivaroxaban—Hypersensitivity—Epirubicin—ovarian cancer	0.000107	0.000585	CcSEcCtD
Rivaroxaban—Urticaria—Doxorubicin—ovarian cancer	0.000106	0.000584	CcSEcCtD
Rivaroxaban—Abdominal pain—Doxorubicin—ovarian cancer	0.000106	0.000581	CcSEcCtD
Rivaroxaban—Asthenia—Epirubicin—ovarian cancer	0.000104	0.00057	CcSEcCtD
Rivaroxaban—Pruritus—Epirubicin—ovarian cancer	0.000102	0.000562	CcSEcCtD
Rivaroxaban—Diarrhoea—Epirubicin—ovarian cancer	9.91e-05	0.000543	CcSEcCtD
Rivaroxaban—Hypersensitivity—Doxorubicin—ovarian cancer	9.87e-05	0.000541	CcSEcCtD
Rivaroxaban—Asthenia—Doxorubicin—ovarian cancer	9.61e-05	0.000527	CcSEcCtD
Rivaroxaban—Dizziness—Epirubicin—ovarian cancer	9.58e-05	0.000525	CcSEcCtD
Rivaroxaban—Pruritus—Doxorubicin—ovarian cancer	9.48e-05	0.00052	CcSEcCtD
Rivaroxaban—Vomiting—Epirubicin—ovarian cancer	9.21e-05	0.000505	CcSEcCtD
Rivaroxaban—Diarrhoea—Doxorubicin—ovarian cancer	9.17e-05	0.000503	CcSEcCtD
Rivaroxaban—Rash—Epirubicin—ovarian cancer	9.13e-05	0.000501	CcSEcCtD
Rivaroxaban—Dermatitis—Epirubicin—ovarian cancer	9.12e-05	0.0005	CcSEcCtD
Rivaroxaban—Headache—Epirubicin—ovarian cancer	9.07e-05	0.000498	CcSEcCtD
Rivaroxaban—Dizziness—Doxorubicin—ovarian cancer	8.86e-05	0.000486	CcSEcCtD
Rivaroxaban—Nausea—Epirubicin—ovarian cancer	8.6e-05	0.000472	CcSEcCtD
Rivaroxaban—Vomiting—Doxorubicin—ovarian cancer	8.52e-05	0.000467	CcSEcCtD
Rivaroxaban—Rash—Doxorubicin—ovarian cancer	8.45e-05	0.000463	CcSEcCtD
Rivaroxaban—Dermatitis—Doxorubicin—ovarian cancer	8.44e-05	0.000463	CcSEcCtD
Rivaroxaban—Headache—Doxorubicin—ovarian cancer	8.39e-05	0.00046	CcSEcCtD
Rivaroxaban—Nausea—Doxorubicin—ovarian cancer	7.96e-05	0.000437	CcSEcCtD
